383220:KRXF&F Co., Ltd. Analysis
Data as of 2026-03-12 - not real-time
₩65,300.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
F&F Co., Ltd trades at around 65,300 KRW, well above its DCF‑derived fair value of roughly 20,700 KRW, suggesting a sizable premium. The stock’s 30‑day volatility sits above 50%, indicating a highly choppy price environment. Technicals show a bearish MACD divergence with the histogram deep in negative territory, while the RSI hovers near the neutral 45 level. Volume has been on a downtrend, further dampening short‑term momentum. On the fundamentals side, the company delivers solid profitability with an operating margin near 27% and a net profit margin above 18%. Revenue is growing modestly at 5.2% YoY, supported by strong gross margins exceeding 65%.
Cash generation is robust, with operating cash flow surpassing 360 billion KRW and free cash flow positive, enabling a comfortable dividend payout of 4.17% on a low 18% payout ratio. The balance sheet, however, carries a high debt‑to‑equity ratio of over 20, which tempers the otherwise attractive yield. The beta of 0.24 points to limited systematic risk, yet the consumer‑cyclical sector remains sensitive to economic swings. Given the current price premium, the upside potential is limited, while downside risk remains aligned with the 58,000 KRW support zone. The market sentiment index reads “Extreme Greed,” reflecting investor optimism that may be overstretched. In this context, investors should treat the stock as overvalued in the near term but recognize its underlying cash‑flow strength for longer horizons.
Cash generation is robust, with operating cash flow surpassing 360 billion KRW and free cash flow positive, enabling a comfortable dividend payout of 4.17% on a low 18% payout ratio. The balance sheet, however, carries a high debt‑to‑equity ratio of over 20, which tempers the otherwise attractive yield. The beta of 0.24 points to limited systematic risk, yet the consumer‑cyclical sector remains sensitive to economic swings. Given the current price premium, the upside potential is limited, while downside risk remains aligned with the 58,000 KRW support zone. The market sentiment index reads “Extreme Greed,” reflecting investor optimism that may be overstretched. In this context, investors should treat the stock as overvalued in the near term but recognize its underlying cash‑flow strength for longer horizons.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD histogram
- Current price far above DCF fair value
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong operating cash flow
- Sustainable dividend yield
- Modest revenue growth
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High dividend yield with low payout ratio
- Low beta indicating limited market correlation
- Potential for price correction toward fair value
Key Metrics & Analysis
Financial Health
Revenue Growth5.20%
Profit Margin18.42%
P/E Ratio5.8
ROE21.75%
ROA12.29%
Debt/Equity20.34
Op. Cash Flow₩366.1B
Free Cash Flow₩51.9B
Technical Analysis
TrendNeutral
RSI45.1
Support₩58,000.00
Resistance₩78,400.00
MA 20₩68,785.00
MA 50₩68,158.00
MA 200₩70,351.50
MACDBearish
VolumeDecreasing
Fear & Greed Index76.34
Valuation
Fair Value₩20,738.77
Target Price₩91,818.18
Upside/Downside40.61%
GradeOvervalued
TypeValue
Dividend Yield4.17%
Risk Assessment
Beta0.24
Volatility54.12%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.